‘Thoughtful scientist’ Delnevo a popular choice to chair FDA advisory committee

The US Food and Drug Administration (FDA) has appointed Cristine Delnevo, director of the Rutgers Center for Tobacco Studies at the State University of New Jersey, as chair of the Tobacco Products Scientific Advisory Committee (TPSAC) a choice that has been well received by the scientific community.

Cliff Douglas, director of the University of Michigan Tobacco Research Network, told ECigIntelligence that Delnevo has a good reputation as an “objective, thoughtful scientist”.

...

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information

MORE INFO

Visit store

Check out our reports
available for purchase

View reports

Request a free sample of this report:

“ ‘Thoughtful scientist’ Delnevo a popular choice to chair FDA advisory committee ”

    This file is not available, please fill the form to request your sample page:






    Buy report request information:

    “ ‘Thoughtful scientist’ Delnevo a popular choice to chair FDA advisory committee ”






      The US Food and Drug Administration (FDA) has appointed Cristine Delnevo, director of the Rutgers Center for Tobacco Studies at the State University of New Jersey, as chair of the Tobacco Products Scientific Advisory Committee (TPSAC) a choice that has been well received by the scientific community.

      Cliff Douglas, director of the University of Michigan Tobacco Research Network, told ECigIntelligence that Delnevo has a good reputation as an “objective, thoughtful scientist”.

      ...

      Benefits of subscription plans:

      • Stay informed of any legal and market change in the sector that impacts your organization
      • Maximise resources by getting market and legal data analysis daily in one place
      • Make smart decisions by understanding how the regulatory and market landscape evolves
      • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

      Need help?

      Contact a sales representative right now and don’t wait

      Erik Galavis
      +34 654 320 547
      Email Erik